ClinicalTrials.Veeva

Menu

Supermicrosurgical LVA for Lymphedema Treatment

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Lymphedema

Treatments

Other: LVSEA
Other: LVESA
Other: LVEEA

Study type

Observational

Funder types

Other

Identifiers

NCT04285762
201801774B0

Details and patient eligibility

About

LVA orientations such as lymphaticovenous end-to-end (LVEEA), end-to-side (LVESA), and side-to-end (LVSEA) are commonly performed. Each orientation has its own advantages and disadvantages. The key factors affecting the type of anastomotic orientation are the sizes of the LVs and the RVs, and the relative distance between them. Most published literatures have focused on LVSEA2-9, which is considered to be the most efficient. With one anastomosis in LVSEA, the RV is able to drain both the antegrade and retrograde lymphatic flow. Nevertheless, how to determine the anastomotic orientation has remained ambiguous. In this study, we aimed to establish the basis of selecting the proper anastomotic orientation, based on the size and comparative size discrepancy between LV and RV. To the best of our knowledge, this is the first report to focus on this subject.

Enrollment

100 patients

Sex

All

Ages

20 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • lymphedematous lower limbs (International Society of Lymphology stage I-III) between March 2016 to October 2018 were included

Exclusion criteria

  • Patients whose data were missing will be excluded.

Trial design

100 participants in 1 patient group

Patients underwent supermicrosurgical LVA
Description:
Patients underwent supermicrosurgical LVA by a single surgeon from March 2016 to October 2018.
Treatment:
Other: LVSEA
Other: LVESA
Other: LVEEA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems